title: Botulinum toxin treatment for blepharospasm associated with myasthenia gravis.
authors.forename: Kenju
authors.initials: K
authors.lastname: Hara
authors.forename: Akiko
authors.initials: A
authors.lastname: Matsuda
authors.forename: Yuko
authors.initials: Y
authors.lastname: Kitsukawa
authors.forename: Keiko
authors.initials: K
authors.lastname: Tanaka
authors.forename: Masatoyo
authors.initials: M
authors.lastname: Nishizawa
authors.forename: Asako
authors.initials: A
authors.lastname: Tagawa
mesh_terms: D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001764:Blepharospasm / Q000188:drug therapy* / Q000209:etiology*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D004576:Electromyography / Q000379:methods; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000150:complications* / Q000188:drug therapy
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins